منابع مشابه
VEGFR3 as a novel modulator for PAH
Pulmonary artery hypertension (PAH) is a rare lung disorder in which the arteries that carry blood from the heart to the lungs progressively narrow down, making it difficult for blood to flow through the vessels. In many cases, PAH leads to right ventricular failure. The recent estimate of 1-, 3-, and 5-year survival rates from the time of diagnosis were estimated to be 87.7%, 72.1% , and 60.3%...
متن کاملNovel Cell-Based Therapies in Hepatic Disorders
In the recent decade, liver diseases with high mortality rate have became one of the major health problems worldwide. Liver transplantation is the most effective and the standard treatment for decompensated liver disease, but, shortage of available organs and inaccuracy in modeling of the liver diseases are the most limiting issues in treatment. Regenerative medicine and cell based therapy str...
متن کاملNovel therapies for sarcoidosis.
The treatment of sarcoidosis remains controversial. Corticosteroids remain the cornerstone of therapy, but immunosuppressive, cytotoxic, and immunomodulatory agents have emerged as viable therapeutic options for patients failing or experiencing adverse effects from corticosteroids. Published data are most extensive with methotrexate, but favorable responses have been noted with leflunomide, aza...
متن کاملNovel therapies for cytomegalovirus disease.
Cytomegalovirus (CMV) infection is one of the most important infectious complications of solid-organ transplantation, a serious, life-threatining, opportunistic pathogen in HIV-infected patients, and may cause hearing defects and irreversible central nervous system disease in infants infected during gestation. Four drugs are currently licensed for prophylaxis, pre-emptive therapy, and treatment...
متن کاملNovel Therapies for Heart Failure
February is chosen by both the American Heart Association and British Heart Foundation as the month for heart awareness, and we dedicate this month's editorial to heart failure (HF) — a common and debilitating condition in which unmet medical needs remain globally. HF is a leading cause of hospitalization in people over 65 years of age, andmore than half the patients diewithin 5 years of diagno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advances in Pulmonary Hypertension
سال: 2009
ISSN: 1933-088X
DOI: 10.21693/1933-088x-8.1.17